nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ABCB1—ovarian cancer	0.504	1	CbGaD
Metoprolol—ABCB1—Topotecan—ovarian cancer	0.0682	0.267	CbGbCtD
Metoprolol—ABCB1—Vinorelbine—ovarian cancer	0.048	0.188	CbGbCtD
Metoprolol—CYP2D6—Vinorelbine—ovarian cancer	0.0452	0.177	CbGbCtD
Metoprolol—ABCB1—Paclitaxel—ovarian cancer	0.0337	0.132	CbGbCtD
Metoprolol—ABCB1—Docetaxel—ovarian cancer	0.0244	0.0957	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—ovarian cancer	0.0182	0.0713	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—ovarian cancer	0.0171	0.0672	CbGbCtD
Metoprolol—Pruritus—Vinorelbine—ovarian cancer	0.000301	0.00125	CcSEcCtD
Metoprolol—Breast disorder—Epirubicin—ovarian cancer	0.000301	0.00125	CcSEcCtD
Metoprolol—Mental disorder—Docetaxel—ovarian cancer	0.000299	0.00124	CcSEcCtD
Metoprolol—Chest pain—Paclitaxel—ovarian cancer	0.000298	0.00124	CcSEcCtD
Metoprolol—Arthralgia—Paclitaxel—ovarian cancer	0.000298	0.00124	CcSEcCtD
Metoprolol—Anxiety—Paclitaxel—ovarian cancer	0.000297	0.00124	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000296	0.00123	CcSEcCtD
Metoprolol—Nausea—Topotecan—ovarian cancer	0.000295	0.00123	CcSEcCtD
Metoprolol—Cardiac arrest—Doxorubicin—ovarian cancer	0.000293	0.00122	CcSEcCtD
Metoprolol—Dry mouth—Paclitaxel—ovarian cancer	0.000292	0.00121	CcSEcCtD
Metoprolol—Mood swings—Doxorubicin—ovarian cancer	0.000292	0.00121	CcSEcCtD
Metoprolol—Diarrhoea—Vinorelbine—ovarian cancer	0.000291	0.00121	CcSEcCtD
Metoprolol—Dysgeusia—Docetaxel—ovarian cancer	0.000291	0.00121	CcSEcCtD
Metoprolol—Nausea—Melphalan—ovarian cancer	0.000289	0.0012	CcSEcCtD
Metoprolol—Confusional state—Paclitaxel—ovarian cancer	0.000289	0.0012	CcSEcCtD
Metoprolol—Oedema—Paclitaxel—ovarian cancer	0.000286	0.00119	CcSEcCtD
Metoprolol—Muscle spasms—Docetaxel—ovarian cancer	0.000286	0.00119	CcSEcCtD
Metoprolol—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000284	0.00118	CcSEcCtD
Metoprolol—Shock—Paclitaxel—ovarian cancer	0.000282	0.00117	CcSEcCtD
Metoprolol—Dizziness—Vinorelbine—ovarian cancer	0.000281	0.00117	CcSEcCtD
Metoprolol—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000281	0.00117	CcSEcCtD
Metoprolol—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000281	0.00117	CcSEcCtD
Metoprolol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000281	0.00117	CcSEcCtD
Metoprolol—Angina pectoris—Epirubicin—ovarian cancer	0.00028	0.00116	CcSEcCtD
Metoprolol—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00028	0.00116	CcSEcCtD
Metoprolol—Tachycardia—Paclitaxel—ovarian cancer	0.000279	0.00116	CcSEcCtD
Metoprolol—Breast disorder—Doxorubicin—ovarian cancer	0.000278	0.00116	CcSEcCtD
Metoprolol—Skin disorder—Paclitaxel—ovarian cancer	0.000278	0.00115	CcSEcCtD
Metoprolol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000277	0.00115	CcSEcCtD
Metoprolol—Vomiting—Vinorelbine—ovarian cancer	0.00027	0.00112	CcSEcCtD
Metoprolol—Rash—Vinorelbine—ovarian cancer	0.000268	0.00111	CcSEcCtD
Metoprolol—Dermatitis—Vinorelbine—ovarian cancer	0.000268	0.00111	CcSEcCtD
Metoprolol—Hypotension—Paclitaxel—ovarian cancer	0.000267	0.00111	CcSEcCtD
Metoprolol—Headache—Vinorelbine—ovarian cancer	0.000266	0.00111	CcSEcCtD
Metoprolol—Syncope—Docetaxel—ovarian cancer	0.000266	0.00111	CcSEcCtD
Metoprolol—Leukopenia—Docetaxel—ovarian cancer	0.000266	0.0011	CcSEcCtD
Metoprolol—Palpitations—Docetaxel—ovarian cancer	0.000263	0.00109	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000263	0.00109	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—ovarian cancer	0.000262	0.00109	CcSEcCtD
Metoprolol—Loss of consciousness—Docetaxel—ovarian cancer	0.000261	0.00108	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000261	0.00108	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—ovarian cancer	0.000259	0.00108	CcSEcCtD
Metoprolol—Insomnia—Paclitaxel—ovarian cancer	0.000259	0.00107	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—ovarian cancer	0.000258	0.00107	CcSEcCtD
Metoprolol—Paraesthesia—Paclitaxel—ovarian cancer	0.000257	0.00107	CcSEcCtD
Metoprolol—Hypertension—Docetaxel—ovarian cancer	0.000257	0.00107	CcSEcCtD
Metoprolol—Dyspnoea—Paclitaxel—ovarian cancer	0.000255	0.00106	CcSEcCtD
Metoprolol—Somnolence—Paclitaxel—ovarian cancer	0.000254	0.00106	CcSEcCtD
Metoprolol—Chest pain—Docetaxel—ovarian cancer	0.000253	0.00105	CcSEcCtD
Metoprolol—Arthralgia—Docetaxel—ovarian cancer	0.000253	0.00105	CcSEcCtD
Metoprolol—Nausea—Vinorelbine—ovarian cancer	0.000253	0.00105	CcSEcCtD
Metoprolol—Dyspepsia—Paclitaxel—ovarian cancer	0.000252	0.00105	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000251	0.00104	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—ovarian cancer	0.00025	0.00104	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—ovarian cancer	0.000249	0.00104	CcSEcCtD
Metoprolol—Dry mouth—Docetaxel—ovarian cancer	0.000247	0.00103	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000247	0.00103	CcSEcCtD
Metoprolol—Fatigue—Paclitaxel—ovarian cancer	0.000247	0.00102	CcSEcCtD
Metoprolol—Sweating—Epirubicin—ovarian cancer	0.000246	0.00102	CcSEcCtD
Metoprolol—Pain—Paclitaxel—ovarian cancer	0.000245	0.00102	CcSEcCtD
Metoprolol—Constipation—Paclitaxel—ovarian cancer	0.000245	0.00102	CcSEcCtD
Metoprolol—Confusional state—Docetaxel—ovarian cancer	0.000245	0.00102	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000243	0.00101	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000243	0.00101	CcSEcCtD
Metoprolol—Oedema—Docetaxel—ovarian cancer	0.000243	0.00101	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—ovarian cancer	0.000242	0.00101	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—ovarian cancer	0.000239	0.000994	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—ovarian cancer	0.000239	0.000991	CcSEcCtD
Metoprolol—Shock—Docetaxel—ovarian cancer	0.000239	0.000991	CcSEcCtD
Metoprolol—Nervous system disorder—Docetaxel—ovarian cancer	0.000238	0.000988	CcSEcCtD
Metoprolol—Thrombocytopenia—Docetaxel—ovarian cancer	0.000237	0.000986	CcSEcCtD
Metoprolol—Tachycardia—Docetaxel—ovarian cancer	0.000237	0.000983	CcSEcCtD
Metoprolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000236	0.000979	CcSEcCtD
Metoprolol—Skin disorder—Docetaxel—ovarian cancer	0.000236	0.000978	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—ovarian cancer	0.000234	0.000973	CcSEcCtD
Metoprolol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000234	0.000972	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—ovarian cancer	0.000231	0.000961	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—ovarian cancer	0.000231	0.000958	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000231	0.000958	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—ovarian cancer	0.00023	0.000956	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—ovarian cancer	0.000228	0.000945	CcSEcCtD
Metoprolol—Urticaria—Paclitaxel—ovarian cancer	0.000227	0.000944	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—ovarian cancer	0.000227	0.000942	CcSEcCtD
Metoprolol—Hypotension—Docetaxel—ovarian cancer	0.000227	0.000941	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000226	0.00094	CcSEcCtD
Metoprolol—Abdominal pain—Paclitaxel—ovarian cancer	0.000226	0.000939	CcSEcCtD
Metoprolol—Body temperature increased—Paclitaxel—ovarian cancer	0.000226	0.000939	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000224	0.000932	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—ovarian cancer	0.000222	0.000921	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—ovarian cancer	0.000221	0.00092	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000221	0.000917	CcSEcCtD
Metoprolol—Insomnia—Docetaxel—ovarian cancer	0.000219	0.000911	CcSEcCtD
Metoprolol—Paraesthesia—Docetaxel—ovarian cancer	0.000218	0.000904	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—ovarian cancer	0.000217	0.000901	CcSEcCtD
Metoprolol—Dyspnoea—Docetaxel—ovarian cancer	0.000216	0.000898	CcSEcCtD
Metoprolol—Somnolence—Docetaxel—ovarian cancer	0.000216	0.000895	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—ovarian cancer	0.000215	0.000893	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—ovarian cancer	0.000215	0.000891	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—ovarian cancer	0.000214	0.000887	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—ovarian cancer	0.000214	0.000887	CcSEcCtD
Metoprolol—Dyspepsia—Docetaxel—ovarian cancer	0.000213	0.000886	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—ovarian cancer	0.000213	0.000885	CcSEcCtD
Metoprolol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000211	0.000875	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—ovarian cancer	0.00021	0.000871	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000209	0.000869	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000209	0.000869	CcSEcCtD
Metoprolol—Fatigue—Docetaxel—ovarian cancer	0.000209	0.000868	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—ovarian cancer	0.000209	0.000867	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—ovarian cancer	0.000208	0.000864	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000208	0.000862	CcSEcCtD
Metoprolol—Pain—Docetaxel—ovarian cancer	0.000207	0.000861	CcSEcCtD
Metoprolol—Constipation—Docetaxel—ovarian cancer	0.000207	0.000861	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—ovarian cancer	0.000206	0.000854	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—ovarian cancer	0.000205	0.000853	CcSEcCtD
Metoprolol—Asthenia—Paclitaxel—ovarian cancer	0.000205	0.000852	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—ovarian cancer	0.000203	0.000845	CcSEcCtD
Metoprolol—Pruritus—Paclitaxel—ovarian cancer	0.000202	0.000841	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—ovarian cancer	0.000202	0.000838	CcSEcCtD
Metoprolol—Feeling abnormal—Docetaxel—ovarian cancer	0.0002	0.00083	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—ovarian cancer	0.000199	0.000827	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—ovarian cancer	0.000199	0.000825	CcSEcCtD
Metoprolol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000198	0.000823	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000198	0.000821	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—ovarian cancer	0.000198	0.00082	CcSEcCtD
Metoprolol—Tension—Epirubicin—ovarian cancer	0.000197	0.000817	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—ovarian cancer	0.000196	0.000815	CcSEcCtD
Metoprolol—Diarrhoea—Paclitaxel—ovarian cancer	0.000196	0.000813	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—ovarian cancer	0.000195	0.000808	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—ovarian cancer	0.000193	0.000803	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—ovarian cancer	0.000193	0.0008	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—ovarian cancer	0.000192	0.000799	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000192	0.000797	CcSEcCtD
Metoprolol—Abdominal pain—Docetaxel—ovarian cancer	0.000192	0.000796	CcSEcCtD
Metoprolol—Body temperature increased—Docetaxel—ovarian cancer	0.000192	0.000796	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—ovarian cancer	0.00019	0.00079	CcSEcCtD
Metoprolol—Dizziness—Paclitaxel—ovarian cancer	0.000189	0.000786	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—ovarian cancer	0.000189	0.000784	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—ovarian cancer	0.000188	0.000782	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—ovarian cancer	0.000187	0.000775	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—ovarian cancer	0.000183	0.000759	CcSEcCtD
Metoprolol—Tension—Doxorubicin—ovarian cancer	0.000182	0.000756	CcSEcCtD
Metoprolol—Vomiting—Paclitaxel—ovarian cancer	0.000182	0.000755	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—ovarian cancer	0.000182	0.000754	CcSEcCtD
Metoprolol—Rash—Paclitaxel—ovarian cancer	0.00018	0.000749	CcSEcCtD
Metoprolol—Dermatitis—Paclitaxel—ovarian cancer	0.00018	0.000748	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—ovarian cancer	0.00018	0.000748	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—ovarian cancer	0.00018	0.000748	CcSEcCtD
Metoprolol—Syncope—Epirubicin—ovarian cancer	0.00018	0.000746	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—ovarian cancer	0.000179	0.000745	CcSEcCtD
Metoprolol—Headache—Paclitaxel—ovarian cancer	0.000179	0.000744	CcSEcCtD
Metoprolol—Hypersensitivity—Docetaxel—ovarian cancer	0.000179	0.000742	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—ovarian cancer	0.000178	0.00074	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—ovarian cancer	0.000177	0.000735	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—ovarian cancer	0.000176	0.000732	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—ovarian cancer	0.000175	0.000726	CcSEcCtD
Metoprolol—Asthenia—Docetaxel—ovarian cancer	0.000174	0.000723	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—ovarian cancer	0.000173	0.000719	CcSEcCtD
Metoprolol—Pruritus—Docetaxel—ovarian cancer	0.000172	0.000712	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—ovarian cancer	0.000171	0.000709	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—ovarian cancer	0.000171	0.000709	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—ovarian cancer	0.00017	0.000706	CcSEcCtD
Metoprolol—Nausea—Paclitaxel—ovarian cancer	0.00017	0.000706	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000169	0.000704	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—ovarian cancer	0.000167	0.000693	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—ovarian cancer	0.000167	0.000692	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—ovarian cancer	0.000166	0.000691	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—ovarian cancer	0.000166	0.000689	CcSEcCtD
Metoprolol—Diarrhoea—Docetaxel—ovarian cancer	0.000166	0.000689	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—ovarian cancer	0.000165	0.000685	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—ovarian cancer	0.000164	0.000681	CcSEcCtD
Metoprolol—Oedema—Epirubicin—ovarian cancer	0.000164	0.000679	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000163	0.000677	CcSEcCtD
Metoprolol—Shock—Epirubicin—ovarian cancer	0.000161	0.000668	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—ovarian cancer	0.00016	0.000666	CcSEcCtD
Metoprolol—Dizziness—Docetaxel—ovarian cancer	0.00016	0.000666	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—ovarian cancer	0.00016	0.000665	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—ovarian cancer	0.00016	0.000665	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—ovarian cancer	0.00016	0.000663	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—ovarian cancer	0.000159	0.00066	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000158	0.000657	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—ovarian cancer	0.000158	0.000656	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—ovarian cancer	0.000158	0.000656	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—ovarian cancer	0.000157	0.000653	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000157	0.000651	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—ovarian cancer	0.000154	0.000641	CcSEcCtD
Metoprolol—Vomiting—Docetaxel—ovarian cancer	0.000154	0.00064	CcSEcCtD
Metoprolol—Rash—Docetaxel—ovarian cancer	0.000153	0.000635	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—ovarian cancer	0.000153	0.000635	CcSEcCtD
Metoprolol—Dermatitis—Docetaxel—ovarian cancer	0.000153	0.000634	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—ovarian cancer	0.000153	0.000634	CcSEcCtD
Metoprolol—Headache—Docetaxel—ovarian cancer	0.000152	0.000631	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—ovarian cancer	0.000151	0.000628	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000149	0.000619	CcSEcCtD
Metoprolol—Shock—Doxorubicin—ovarian cancer	0.000149	0.000618	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000148	0.000616	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000148	0.000615	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—ovarian cancer	0.000148	0.000614	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—ovarian cancer	0.000148	0.000613	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—ovarian cancer	0.000147	0.00061	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—ovarian cancer	0.000147	0.00061	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000146	0.000608	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—ovarian cancer	0.000146	0.000606	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—ovarian cancer	0.000145	0.000604	CcSEcCtD
Metoprolol—Nausea—Docetaxel—ovarian cancer	0.000144	0.000598	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—ovarian cancer	0.000144	0.000598	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—ovarian cancer	0.000141	0.000587	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000141	0.000586	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—ovarian cancer	0.000141	0.000586	CcSEcCtD
Metoprolol—Pain—Epirubicin—ovarian cancer	0.00014	0.000581	CcSEcCtD
Metoprolol—Constipation—Epirubicin—ovarian cancer	0.00014	0.000581	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000138	0.000573	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—ovarian cancer	0.000137	0.000568	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—ovarian cancer	0.000136	0.000564	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—ovarian cancer	0.000135	0.00056	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—ovarian cancer	0.000135	0.00056	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—ovarian cancer	0.000135	0.000559	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000134	0.000555	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—ovarian cancer	0.000133	0.000553	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000131	0.000543	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—ovarian cancer	0.00013	0.000542	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—ovarian cancer	0.00013	0.00054	CcSEcCtD
Metoprolol—Pain—Doxorubicin—ovarian cancer	0.000129	0.000537	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—ovarian cancer	0.000129	0.000537	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—ovarian cancer	0.000129	0.000537	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—ovarian cancer	0.000129	0.000537	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000125	0.000518	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000124	0.000514	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—ovarian cancer	0.000121	0.0005	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—ovarian cancer	0.00012	0.000499	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—ovarian cancer	0.00012	0.000497	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—ovarian cancer	0.00012	0.000497	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—ovarian cancer	0.000117	0.000487	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—ovarian cancer	0.000116	0.000481	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—ovarian cancer	0.000112	0.000465	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000112	0.000463	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—ovarian cancer	0.000109	0.000451	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—ovarian cancer	0.000108	0.000449	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—ovarian cancer	0.000107	0.000445	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—ovarian cancer	0.000104	0.000432	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—ovarian cancer	0.000104	0.00043	CcSEcCtD
Metoprolol—Rash—Epirubicin—ovarian cancer	0.000103	0.000428	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—ovarian cancer	0.000103	0.000428	CcSEcCtD
Metoprolol—Headache—Epirubicin—ovarian cancer	0.000102	0.000426	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—ovarian cancer	0.0001	0.000416	CcSEcCtD
Metoprolol—Nausea—Epirubicin—ovarian cancer	9.72e-05	0.000403	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—ovarian cancer	9.62e-05	0.0004	CcSEcCtD
Metoprolol—Rash—Doxorubicin—ovarian cancer	9.54e-05	0.000396	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—ovarian cancer	9.53e-05	0.000396	CcSEcCtD
Metoprolol—Headache—Doxorubicin—ovarian cancer	9.48e-05	0.000394	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—ovarian cancer	8.99e-05	0.000373	CcSEcCtD
Metoprolol—Atenolol—ABCB1—ovarian cancer	8.82e-05	0.432	CrCbGaD
Metoprolol—Acebutolol—ABCB1—ovarian cancer	8.14e-05	0.398	CrCbGaD
Metoprolol—Propranolol—ABCB1—ovarian cancer	3.47e-05	0.17	CrCbGaD
